{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000004","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.196766+00:00","generated_at":"2026-05-28T03:25:01.685898+00:00","sec_items":["1.01","3.02","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Salarius to merge with Decoy; Decoy valued at $28M, legacy holders ~14.1% ownership","bullets":["Merger structured as stock-for-stock with Decoy valued at $28M and Salarius at $4.6M, based on cash at close.","Legacy Salarius stockholders retain ~14.1%; Decoy stockholders own ~85.9% of combined company.","Closing conditioned on minimum $6M Qualified Financing and continued Nasdaq listing.","Combined company to focus on Decoy's IMP3ACT peptide platform, SP-3164 P-PROTACs; initial targets antivirals and CRC.","Salarius paid $350K to cancel a warrant for 454,546 shares; SP-2577 program remains on partial clinical hold."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000004","json":"https://secwatch.observer/filing/0001615219-25-000004.json","markdown":"https://secwatch.observer/filing/0001615219-25-000004.md","text":"https://secwatch.observer/filing/0001615219-25-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000004/0001615219-25-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000004/flks-20250110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:25:01.685898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}